Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer

  Free Subscription


15.07.2019

1 Acta Med Port
1 Acta Oncol
2 Am J Obstet Gynecol
1 Anticancer Res
1 Artif Cells Nanomed Biotechnol
5 Asian Pac J Cancer Prev
1 Biomater Sci
1 Biosci Rep
1 BMC Health Serv Res
1 BMC Med Res Methodol
2 BMC Womens Health
4 Brachytherapy
1 Cad Saude Publica
1 Cancer Causes Control
1 Cancer Res
1 Cancer Res Treat
1 Curr Oncol
1 Curr Probl Cancer
1 Ecancermedicalscience
5 Eur Rev Med Pharmacol Sci
1 Folia Med (Plovdiv)
1 Gene
2 Gynecol Oncol
1 Health Lit Res Pract
1 Int J Exp Pathol
1 Int J Infect Dis
2 Int J Mol Sci
1 Int J Pharm
1 J Clin Psychol Med Settings
1 J Oncol
1 Minerva Med
3 Oncol Lett
1 Photochem Photobiol Sci
1 Physiol Rep
1 Radiat Oncol
2 Sci Rep
1 Sex Transm Dis
1 Taiwan J Obstet Gynecol
1 Zhongguo Yi Xue Ke Xue Yuan Xue Bao
2 Zhonghua Fu Chan Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Med Port

  1. TEIXEIRA C, Pereira AM, Anes E, Rodrigues C, et al
    [Time-Trends in Cervical Cancer Mortality in Portugal].
    Acta Med Port. 2019;32:427-433.
    PubMed     Text format     Abstract available


    Acta Oncol

  2. CHRISTENSEN JT, Gronhoj C, Zamani M, Brask J, et al
    Association between oropharyngeal cancers with known HPV and p16 status and cervical intraepithelial neoplasia: a Danish population-based study.
    Acta Oncol. 2019;58:267-272.
    PubMed     Text format     Abstract available


    Am J Obstet Gynecol

  3. OLIVEIRA CR, Hosier H, Pate B, Niccolai LM, et al
    Compliance with Cervical Cancer Screening Guidelines in Young Females: Rates and Trends of Screening in New Haven County, CT.
    Am J Obstet Gynecol. 2019 Jul 4. pii: S0002-9378(19)30886.
    PubMed     Text format    

  4. CUSIMANO MC, Baxter NN, Gien LT, Moineddin R, et al
    Impact of Surgical Approach on Oncologic Outcomes in Women Undergoing Radical Hysterectomy for Cervical Cancer.
    Am J Obstet Gynecol. 2019 Jul 6. pii: S0002-9378(19)30893.
    PubMed     Text format     Abstract available


    Anticancer Res

  5. LIN CH, Peng SF, Chueh FS, Cheng ZY, et al
    The Ethanol Crude Extraction of Cyperus Rotundus Regulates Apoptosis-associated Gene Expression in HeLa Human Cervical Carcinoma Cells In Vitro.
    Anticancer Res. 2019;39:3697-3709.
    PubMed     Text format     Abstract available


    Artif Cells Nanomed Biotechnol

  6. WANG Y, Liu L, Chen Z
    Transcriptome profiling of cervical cancer cells acquired resistance to cisplatin by deep sequencing.
    Artif Cells Nanomed Biotechnol. 2019;47:2820-2829.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  7. SRISOMBOON S, Tantipalakorn C, Charoenkwan K, Srisomboon J, et al
    Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix
    Asian Pac J Cancer Prev. 2019;20:377-382.
    PubMed     Text format     Abstract available

  8. SHANKAR A, Patil J, Sethi N, Chakraborty A, et al
    Urinary Dysfunction Assessment in Long-Term Survivors of Carcinoma Cervix Using LENT SOMA Scale: An Indian Study Addressing Quality of Life Issues
    Asian Pac J Cancer Prev. 2019;20:383-389.
    PubMed     Text format     Abstract available

  9. AYDOGMUS H, Aydogmus S
    Comparison of Colposcopic Biopsy Results of Patients Who have Cytomorphological Normal but HPV 16-18 or Other High-Risk HPV Subtypes Positive
    Asian Pac J Cancer Prev. 2019;20:417-420.
    PubMed     Text format     Abstract available

  10. INOUE S, Ito H, Hosono S, Hori M, et al
    Net Survival of Elderly Patients with Gynecological Cancer Aged Over 75 Years in 2006-2008
    Asian Pac J Cancer Prev. 2019;20:437-442.
    PubMed     Text format     Abstract available

  11. GHOSH D, Roy AK, Murmu N, Mandal S, et al
    Risk Categorization with Different Grades of Cervical Pre-Neoplastic Lesions - High Risk HPV Associations and Expression of p53 and RARbeta
    Asian Pac J Cancer Prev. 2019;20:549-555.
    PubMed     Text format     Abstract available


    Biomater Sci

  12. WANG X, Wang L, Zong S, Qiu R, et al
    Use of multifunctional composite nanofibers for photothermalchemotherapy to treat cervical cancer in mice.
    Biomater Sci. 2019 Jul 10. doi: 10.1039/c9bm00756.
    PubMed     Text format     Abstract available


    Biosci Rep

  13. HAN L, Husaiyin S, Ma C, Wang L, et al
    TNFAIP8L1 and FLT1 Polymorphisms Alter the Susceptibility to Cervical Cancer among Uyghur Females in China.
    Biosci Rep. 2019 Jul 9. pii: BSR20191155. doi: 10.1042/BSR20191155.
    PubMed     Text format     Abstract available


    BMC Health Serv Res

  14. GABAZA C, Chonzi P, Chadambuka A, Shambira G, et al
    Utilization and outcomes of cervical cancer screening services in Harare City, 2012-2016: a secondary data analysis.
    BMC Health Serv Res. 2019;19:454.
    PubMed     Text format     Abstract available


    BMC Med Res Methodol

  15. QURESHI SA, Gele A, Kour P, Moen KA, et al
    A community-based intervention to increase participation in cervical cancer screening among immigrants in Norway.
    BMC Med Res Methodol. 2019;19:147.
    PubMed     Text format     Abstract available


    BMC Womens Health

  16. TAPERA O, Dreyer G, Kadzatsa W, Nyakabau AM, et al
    Cervical cancer knowledge, attitudes, beliefs and practices of women aged at least 25 years in Harare, Zimbabwe.
    BMC Womens Health. 2019;19:91.
    PubMed     Text format     Abstract available

  17. WIIK J, Sengpiel V, Kyrgiou M, Nilsson S, et al
    Cervical microbiota in women with cervical intra-epithelial neoplasia, prior to and after local excisional treatment, a Norwegian cohort study.
    BMC Womens Health. 2019;19:30.
    PubMed     Text format     Abstract available


    Brachytherapy

  18. LIN AJ, Hassanzadeh C, Markovina S, Schwarz J, et al
    Brachytherapy and survival in small cell cancer of the cervix and uterus.
    Brachytherapy. 2019;18:163-170.
    PubMed     Text format     Abstract available

  19. DA SILVA VTM, Fortuna Diniz AP, Martins J, Cursino K, et al
    Use of interstitial brachytherapy in pelvic recurrence of cervical carcinoma: Clinical response, survival, and toxicity.
    Brachytherapy. 2019;18:146-153.
    PubMed     Text format     Abstract available

  20. SHUKLA AK, Rana BS, Singh NP, Kumar S, et al
    Dosimetric study of CO-60 source step size in uterine cervix intracavitary HDR brachytherapy.
    Brachytherapy. 2019;18:180-185.
    PubMed     Text format     Abstract available

  21. WU PY, Wong TPW, Yip YYC, Chang TYA, et al
    MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
    Brachytherapy. 2019;18:171-179.
    PubMed     Text format     Abstract available


    Cad Saude Publica

  22. RIBEIRO CM, Dias MBK, Pla MAS, Correa FM, et al
    [Parameters for programming line of care procedures for cervical cancer in Brazil].
    Cad Saude Publica. 2019;35:e00183118.
    PubMed     Text format     Abstract available


    Cancer Causes Control

  23. ALLAIRE BT, Ekweme D, Hoerger TJ, DeGroff A, et al
    Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.
    Cancer Causes Control. 2019 Jul 11. pii: 10.1007/s10552-019-01200.
    PubMed     Text format     Abstract available


    Cancer Res

  24. ARROYO-MUHR LS, Lagheden C, Hultin E, Eklund C, et al
    The HPV16 genome is stable in women who progress to in situ or invasive cervical cancer: a prospective population-based study.
    Cancer Res. 2019 Jul 9. pii: 0008-5472.CAN-18-3933.
    PubMed     Text format     Abstract available


    Cancer Res Treat

  25. LIN W, Wang Y, Liu Z, Chen B, et al
    Inequalities in Awareness and Attitude towards HPV and Its Vaccine between Local and Migrant Residents Who Participated in Cervical Cancer Screening in Shenzhen, China.
    Cancer Res Treat. 2019 Jul 1. pii: crt.2019.053. doi: 10.4143/crt.2019.
    PubMed     Text format     Abstract available


    Curr Oncol

  26. HOU Y, Guo S, Lyu J, Lu Z, et al
    Prognostic factors in Asian and white American patients with cervical cancer, considering competing risks.
    Curr Oncol. 2019;26:e277-e285.
    PubMed     Text format     Abstract available


    Curr Probl Cancer

  27. FANI M, Mahmoodi P, Emadzadeh M, Avan A, et al
    Correlation of human papillomavirus 16 and 18 with cervical cancer and their diagnosis methods in Iranian women: A systematic review and meta-analysis.
    Curr Probl Cancer. 2019 Jul 2. pii: S0147-0272(18)30478.
    PubMed     Text format     Abstract available


    Ecancermedicalscience

  28. GIAVEDONI ME, Staringer L, Garrido R, Bertoncini C, et al
    Experience with concurrent chemoradiotherapy treatment in advanced cervical cancer: results from a hospital in Argentina.
    Ecancermedicalscience. 2019;13:919.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  29. SUN XY, Han XM, Zhao XL, Cheng XM, et al
    MiR-93-5p promotes cervical cancer progression by targeting THBS2/MMPS signal pathway.
    Eur Rev Med Pharmacol Sci. 2019;23:5113-5121.
    PubMed     Text format     Abstract available

  30. WEI H, He WR, Chen KM, Wang XW, et al
    MiR-101 affects proliferation and apoptosis of cervical cancer cells by inhibition of JAK2.
    Eur Rev Med Pharmacol Sci. 2019;23:5640-5647.
    PubMed     Text format     Abstract available

  31. LIU CQ, Chen Y, Xie BF, Li YL, et al
    MicroRNA-215-3p suppresses the growth and metastasis of cervical cancer cell via targeting SOX9.
    Eur Rev Med Pharmacol Sci. 2019;23:5628-5639.
    PubMed     Text format     Abstract available

  32. YU Y, Zhao JD, Yang H
    MiR-299-3p inhibits proliferation and invasion of cervical cancer cell via targeting TCF4.
    Eur Rev Med Pharmacol Sci. 2019;23:5621-5627.
    PubMed     Text format     Abstract available

  33. LIU CN, Zhang HY, Liu CL, Wang CC, et al
    Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/beta-catenin pathway.
    Eur Rev Med Pharmacol Sci. 2019;23:5611-5620.
    PubMed     Text format     Abstract available


    Folia Med (Plovdiv)

  34. GAD MM, Galal SB, Helmy W, Abd El-Fattah NH, et al
    Screening of Cervical Cancer: Visual Inspection with Acetic Acid (VIA) and Site of Lesion Verified by Multiple Punch Biopsies.
    Folia Med (Plovdiv). 2019;61:289-295.
    PubMed     Text format     Abstract available


    Gene

  35. BANERJEE S, Karunagaran D
    An integrated approach for mining precise RNA-based cervical cancer staging biomarkers.
    Gene. 2019;712:143961.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  36. ALIMENA S, Yang DD, Melamed A, Mahal BA, et al
    Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
    Gynecol Oncol. 2019 Jul 7. pii: S0090-8258(19)31338.
    PubMed     Text format     Abstract available

  37. SUZUKI K, Nagao S, Shibutani T, Yamamoto K, et al
    Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer.
    Gynecol Oncol. 2019 Jul 5. pii: S0090-8258(19)31262.
    PubMed     Text format     Abstract available


    Health Lit Res Pract

  38. FLORES BE, Acton G, Arevalo-Flechas L, Gill S, et al
    Health Literacy and Cervical Cancer Screening Among Mexican-American Women.
    Health Lit Res Pract. 2019;3:e1-e8.
    PubMed     Text format     Abstract available


    Int J Exp Pathol

  39. HE Y, Xu L, Feng M, Wang W, et al
    Role of CD97 small isoform in human cervical carcinoma.
    Int J Exp Pathol. 2019;100:19-24.
    PubMed     Text format     Abstract available


    Int J Infect Dis

  40. FITZPATRICK MB, Dube Mandishora RS, Katzenstein DA, McCarty K, et al
    hrHPV prevalence and type distribution in rural Zimbabwe: A community-based self-collection study using near-point-of-care GeneXpert HPV testing.
    Int J Infect Dis. 2019;82:21-29.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  41. LIU JJ, Ho JY, Lee HW, Baik MW, et al
    Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer.
    Int J Mol Sci. 2019;20.
    PubMed     Text format     Abstract available

  42. WANG Q, Steger A, Mahner S, Jeschke U, et al
    The Formation and Therapeutic Update of Tumor-Associated Macrophages in Cervical Cancer.
    Int J Mol Sci. 2019;20.
    PubMed     Text format     Abstract available


    Int J Pharm

  43. FIGUEIREDO J, Lopes-Nunes J, Carvalho J, Antunes F, et al
    AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
    Int J Pharm. 2019 Jul 10:118511. doi: 10.1016/j.ijpharm.2019.118511.
    PubMed     Text format     Abstract available


    J Clin Psychol Med Settings

  44. LOPES AC, Bacalhau R, Santos M, Pereira M, et al
    Contribution of Sociodemographic, Clinical, and Psychological Variables to Quality of Life in Women with Cervical Cancer in the Follow-Up Phase.
    J Clin Psychol Med Settings. 2019 Jul 10. pii: 10.1007/s10880-019-09644.
    PubMed     Text format     Abstract available


    J Oncol

  45. MACEDO ACL, Goncalves JCN, Bavaresco DV, Grande AJ, et al
    Accuracy of mRNA HPV Tests for Triage of Precursor Lesions and Cervical Cancer: A Systematic Review and Meta-Analysis.
    J Oncol. 2019;2019:6935030.
    PubMed     Text format     Abstract available


    Minerva Med

  46. TIAN Q, Liu J, Xia S, Wang L, et al
    Association between HPV16 infection and expression of ERK12 signaling pathway in cervical cancer.
    Minerva Med. 2019 Jul 5. pii: S0026-4806.19.06183.
    PubMed     Text format    


    Oncol Lett

  47. ORGANISTA-NAVA J, Gomez-Gomez Y, Garibay-Cerdenares OL, Leyva-Vazquez MA, et al
    Cervical cancer stem cell-associated genes: Prognostic implications in cervical cancer.
    Oncol Lett. 2019;18:7-14.
    PubMed     Text format     Abstract available

  48. XU ML, Kim HJ, Kim SC, Ju W, et al
    Serum anti-GAPDH autoantibody levels reflect the severity of cervical lesions: A potential serum biomarker for cervical cancer screening.
    Oncol Lett. 2019;18:255-264.
    PubMed     Text format     Abstract available

  49. ALIWAINI S, Awadallah AM, Morjan RY, Ghunaim M, et al
    Novel imidazo[1,2-a]pyridine inhibits AKT/mTOR pathway and induces cell cycle arrest and apoptosis in melanoma and cervical cancer cells.
    Oncol Lett. 2019;18:830-837.
    PubMed     Text format     Abstract available


    Photochem Photobiol Sci

  50. SCHAFFER P, Batash R, Ertl-Wagner B, Hofstetter A, et al
    Treatment of cervix carcinoma FIGO IIIb with Photofrin II as a radiosensitizer: a case report.
    Photochem Photobiol Sci. 2019;18:1275-1279.
    PubMed     Text format     Abstract available


    Physiol Rep

  51. NUMATA T, Sato-Numata K, Okada Y
    TRPM7 is involved in acid-induced necrotic cell death in a manner sensitive to progesterone in human cervical cancer cells.
    Physiol Rep. 2019;7:e14157.
    PubMed     Text format     Abstract available


    Radiat Oncol

  52. VISSER J, de Boer P, Crama KF, van Kesteren Z, et al
    Dosimetric comparison of library of plans and online MRI-guided radiotherapy of cervical cancer in the presence of intrafraction anatomical changes.
    Radiat Oncol. 2019;14:126.
    PubMed     Text format     Abstract available


    Sci Rep

  53. CAMPOS-ROMERO A, Anderson KS, Longatto-Filho A, Luna-Ruiz Esparza MA, et al
    The burden of 14 hr-HPV genotypes in women attending routine cervical cancer screening in 20 states of Mexico: a cross-sectional study.
    Sci Rep. 2019;9:10094.
    PubMed     Text format     Abstract available

  54. PANDEY NO, Chauhan AV, Raithatha NS, Patel PK, et al
    Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.
    Sci Rep. 2019;9:9729.
    PubMed     Text format     Abstract available


    Sex Transm Dis

  55. WANG MZ, Feng RM, Wang S, Duan XZ, et al
    Clinical Performance of Human Papillomavirus Testing and Visual Inspection With Acetic Acid in Primary, Combination, and Sequential Cervical Cancer Screening in China.
    Sex Transm Dis. 2019;46:540-547.
    PubMed     Text format     Abstract available


    Taiwan J Obstet Gynecol

  56. CHAO YS, Clark M, Carson E, Weeks L, et al
    Metastatic cervical carcinoma to the thyroid gland: A rare diagnosis.
    Taiwan J Obstet Gynecol. 2019;58:298-299.
    PubMed     Text format     Abstract available


    Zhongguo Yi Xue Ke Xue Yuan Xue Bao

  57. ZHEN HN, Miao Z, Lian X, Hu K, et al
    [Information Needs and Quality among Cervical Cancer Patients].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41:388-395.
    PubMed     Text format     Abstract available


    Zhonghua Fu Chan Ke Za Zhi

  58. OU ZJ, Zhao D, An JS, Sun CY, et al
    [Analysis of prognostic factors and therapeutic patterns of recurrent stage b-a cervical squamous carcinoma treated with radical hysterectomy].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:399-405.
    PubMed     Text format     Abstract available

  59. CAO QW, You ZX, Qian XY, Heng D, et al
    [Discussion on the diagnosis and treatment of high-grade squamous intraepithelial lesions in post-menopausal women].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:393-398.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: